Efficacy of a participation-oriented outpatient neurorehabilitation program in patients with chronic acquired brain injury

Not Applicable

• Conditions: I61; I63; S06; Intracerebral haemorrhage; Cerebral infarction; Intracranial injury

• Registration Number: DRKS00009602
• Lead Sponsor: eurologische KlinikKlinikum der Universität München

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2015-09-30
• Study Start: 2015-11-19
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

Stroke or traumatic brain injury at least 6 months prior to enrollment,
Discharge from inpatient neurorehabilitation at least 3 months prior to enrollment,
Daily commute to the Burgau treatment site feasible,
Capability to endure at least 6 hours of daily therapy,
Life expectancy of at least 1 year,
Informed consent by patient or legal representative,
Age: 18-85 years

Exclusion Criteria

Lack of participation impairment,
Insufficient German language skills,
Unwillingness of health care plan to cover the associated treatment costs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Achieving an individually defined therapeutic goal, assessed by means of the Goal Attainment Scale (GAS) at the start of the study (t1), after 1 month (t2), after 3 months (t3), after 4 months (t4), after 6 months (t5), and after 12 months (t6; all time points given in relation to the baseline t1 measurement)

Secondary Outcome Measures

Name	Time	Method
Improvement of the independence in the activities of daily living (measured by FIM), improvement of the quality of life (measured by EuroQOL, SF-36), improvement of life participation (measured by WHODAS II), reduction of caregiver strain (measured by mCSI), each at the start of the study (t1), after 1 month (t2), after 3 months (t3), after 4 months (t4), after 6 months (t5), and after 12 months (t6; all time points given in relation to the baseline t1 measurement)